U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
125371125371Trans-Rectal Ultrasound-Guided (TRUS) Adverse EventsCompletedNo Results AvailableProstate Cancerhttps://ClinicalTrials.gov/show/NCT00923416
125372125372Efficacy of Sterol-Fortified Low Fat Soy Beverage on Cholesterol Metabolism, Inflammation and Oxidative Status in Humans - Study IICompletedNo Results AvailableHypercholesterolemiaDietary Supplement: plant sterol enriched soymilk|Dietary Supplement: control dairy milkhttps://ClinicalTrials.gov/show/NCT00923403
125373125373Phase 1/2 Study of Metastatic Renal Cancer Using T-Cells Transduced With a T-Cell Receptor Which Recognizes TRAIL Bound to the DR4 ReceptorTerminatedNo Results AvailableRenal Cancer|Kidney CancerGenetic: 2G-1 TCR Retroviral Vector-Transduced lyn|Drug: Aldesleukin|Drug: Cyclophosphamide|Drug: Fludarabine|Drug: (PG13-A(F/K-F-SGSG-T2a-B (opt) (2G-1 TCR) retroviral vector-transduced lymphocytehttps://ClinicalTrials.gov/show/NCT00923390
125374125374Breast Stem Cells in Women at Average Risk and Increased Risk for Breast CancerCompletedNo Results AvailableBreast Cancerhttps://ClinicalTrials.gov/show/NCT00923377
125375125375Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMACActive, not recruitingNo Results AvailableMDS|Immunodeficiency|GATA2Drug: Cyclophosphamide (CTX, Cytoxan)|Drug: Fludarabine(Fludara,Berlex Laboratories)|Procedure: Total Body Irradiation (TBI)|Procedure: Allogeneic HSC|Drug: Equine Anti-Thymocyte Globulinhttps://ClinicalTrials.gov/show/NCT00923364
125376125376Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or NeuroblastomaSuspendedHas ResultsNeuroblastoma|Sarcoma|Rhabdomyosarcoma-Embryonal|Rhabdomyosarcoma- Alveolar|Neuroectodermal Tumors, Primitive, PeripheralDrug: Tumor Purged/CD25 Depleted Lymphocytes|Biological: Tumor Purged/CD25 Depleted Lymphocytes with Tumor Lysate/KLH Pulsed Dendritic Cell Vaccine|Drug: rhIL-7|Biological: Tumor Lysate/KLH Pulsed Dendritic Cell Vaccinehttps://ClinicalTrials.gov/show/NCT00923351
125377125377Clinical Evaluation of the Surgisis Biodesign Vesico-Vaginal Fistula PlugCompletedNo Results AvailableVesico-vaginal FistulaDevice: Surgisis Biodesign (Vesico-vaginal fistula plug)https://ClinicalTrials.gov/show/NCT00923338
125378125378Blood and Tissue Study of Patients in NIH Protocol 08-C-0800CompletedNo Results AvailableEwing's Sarcoma|Osteosarcoma|Rhabdomyosarcoma|Synovial Sarcoma|Other Sarcomahttps://ClinicalTrials.gov/show/NCT00923325
125379125379Trial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)CompletedNo Results AvailableNon Small Cell Lung CancerBiological: CV9201https://ClinicalTrials.gov/show/NCT00923312
125380125380Cetuximab and Trastuzumab in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Previous Treatment With GemcitabineRecruitingNo Results AvailablePancreatic CancerBiological: cetuximab|Biological: trastuzumabhttps://ClinicalTrials.gov/show/NCT00923299
125381125381Sirolimus and Pemetrexed to Treat Non-Small Cell Lung CancerCompletedHas ResultsCarcinoma, Non-Small-Cell LungDrug: FDG-PET|Drug: Pemetrexed|Drug: Sirolimus|Dietary Supplement: Vitamin B12|Dietary Supplement: Folic acid tablets|Drug: Dexamethasone tabletshttps://ClinicalTrials.gov/show/NCT00923273
125382125382Omentectomy and Metabolic SyndromeCompletedHas ResultsMetabolic Syndrome|Morbid ObesityProcedure: Laparoscopic Roux-en-Y Gastric Bypass|Procedure: Omentectomyhttps://ClinicalTrials.gov/show/NCT00923260
125383125383A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)Active, not recruitingNo Results AvailableMedullary Thyroid CarcinomaDrug: Bortezomib|Drug: Vandetanibhttps://ClinicalTrials.gov/show/NCT00923247
125384125384Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic SyndromesTerminatedNo Results AvailableMyelodysplastic Syndromes|Acute Myelogenous LeukemiaDrug: Azacitidine|Drug: Lenalidomidehttps://ClinicalTrials.gov/show/NCT00923234
125385125385Collection of Blood From Patients With Prostate CancerRecruitingNo Results AvailableProstatic Neoplasmshttps://ClinicalTrials.gov/show/NCT00923221
125386125386Radiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic MelanomaCompletedHas ResultsMelanoma|Skin CancerDrug: MART-1: 26-35(27L) Peptide|Drug: Montanide ISA 51 VG|Drug: gp100:154-162 Peptide|Procedure: Radiation|Drug: Aldesleukin|Drug: Fludarabine|Drug: Cyclophosphamide|Genetic: Anti-gp 100:154 TCR PBL|Genetic: Anti-MART-1 F5 TCR PBLhttps://ClinicalTrials.gov/show/NCT00923195
125387125387A Safety Confirmatory Study of Alemtuzumab in Japanese Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaCompletedNo Results AvailableLeukemia, Lymphocytic, Chronic, B-CellDrug: alemtuzumabhttps://ClinicalTrials.gov/show/NCT00923182
125388125388Part 2 of Phase 1 Study of GC1008 to Treat Advanced Melanoma (Part 2 Will Only Accept and Treat Patients With Advanced Malignant Melanoma)CompletedNo Results AvailableRenal Cell CarcinomaDrug: Anti-Transforming Growth Factor-beta (GC 1008)https://ClinicalTrials.gov/show/NCT00923169
125389125389Effects of Aliskiren, Ramipril, and the Combination on Levels of Angiotensin II in Patients With Decompensated Systolic Heart FailureCompletedHas ResultsHeart FailureDrug: aliskiren|Drug: ramipril|Drug: Placebo to aliskiren|Drug: Placebo to ramiprilhttps://ClinicalTrials.gov/show/NCT00923156
125390125390Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney CancerActive, not recruitingNo Results AvailableRenal Cell CarcinomaDrug: Bevacizumab|Drug: Ixabepilonehttps://ClinicalTrials.gov/show/NCT00923130
125391125391Sunitinib to Treat Recurrent Brain CancerTerminatedHas ResultsGlioblastoma Multiforme|Malignant Gliomas|Anaplastic GliomasDrug: Sutent (sunitinib)https://ClinicalTrials.gov/show/NCT00923117
125392125392An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated SkinRecruitingNo Results AvailableBreast Cancer|Healthy Volunteer|Prostate Cancerhttps://ClinicalTrials.gov/show/NCT00923104
125393125393Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in HypertensionCompletedHas ResultsEssential HypertensionDrug: olmesartan medoxomil + amlodipine + hydroclororthiazide + placebo|Drug: Olmesartan medoxomil + amlodipine + hydrochlorothiazide + placebo|Drug: olmesartan medoxomil + amlodipine + hydroclororthiazide|Drug: olmesartan medoxomil + amlodipine + hydroclororthiazide|Drug: olmesartan medoxomil + amlodipine + hydroclororthiazide|Drug: olmesartan medoxomil + amlodipine|Drug: olmesartan medoxomil + amlodipine|Drug: olmesartan medoxomil + amlodipinehttps://ClinicalTrials.gov/show/NCT00923091
125394125394Neurophysiological Targets for Cognitive Training in SchizophreniaCompletedNo Results AvailableSchizophreniaBehavioral: Brain Fitness|Behavioral: Cortex with Insighthttps://ClinicalTrials.gov/show/NCT00923078
125395125395Cancer Care in the National Cancer Institute Center for Cancer ResearchEnrolling by invitationNo Results AvailableNeoplasmshttps://ClinicalTrials.gov/show/NCT00923065
125396125396The Natural History of Solid Organ Cancer Stem Cells (SOCSC)TerminatedNo Results AvailableHepatic Cancer|Pancreatic Ductal Cancer|Colorectal Cancer|Breast Cancer|Gastric Cancerhttps://ClinicalTrials.gov/show/NCT00923052
125397125397The Early Origins of Cardiovascular DiseaseNot yet recruitingNo Results AvailableCardiovascular Diseasehttps://ClinicalTrials.gov/show/NCT00923039
125398125398Follow Up Protocol for Subjects Previously Enrolled in NCI Surgery Branch StudiesEnrolling by invitationNo Results AvailableMelanoma|Adenocarcinoma|Carcinoma NOS|Neuroendocrine Tumorshttps://ClinicalTrials.gov/show/NCT00923026
125399125399Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell LeukemiaRecruitingNo Results AvailableHairy Cell LeukemiaDrug: Cladribine|Drug: Rituximabhttps://ClinicalTrials.gov/show/NCT00923013
125400125400Herb Drug Interaction of Traditional Chinese Herb and Commonly Used DrugsRecruitingNo Results AvailableHealthyDrug: Nalbuphine|Drug: Morphine|Drug: Morphine with Long dan xie gan tang|Drug: Nalbuphine with Long dan xie gan tang|Drug: Nubian with Long dan xie gan tanghttps://ClinicalTrials.gov/show/NCT00923000

* Görseller ve İçerik tekif hakkına sahip olabilir